Dimitrios Mougiakakos

Medizinische Fakultät Professur für CAR-T-Zell-Therapie Professur für Hämatologie mit dem Schwerpunkt Zelluläre Immuntherapie

IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article More on CD19-CAR T Cells in Systemic Lupus Erythematosus (2021) Mougiakakos D, Krönke G, Schett G Journal article, Letter T-Cell Metabolism in Graft Versus Host Disease (2021) Karl F, Hudecek M, Berberich-Siebelt F, Mackensen A, Mougiakakos D Journal article, Review article IMMUNOMONITORING OF CD19. CAR T-CELLS IN LARGE B-CELL LYMPHOMA- A TWO-CENTER EXPERIENCE (2021) Blumenberg V, Völkl S, Busch G, Baumann S, Winkelmann M, Tast B, Nixdorf D, et al. Conference contribution The CAR-HEMATOTOX model identifies patients with a high risk for CAR T-cell related hematotoxicity and is associated with prolonged hospitalization and poor prognosis (2021) Rejeski K, Perez A, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, et al. Conference contribution Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, Bucklein , et al. Conference contribution Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, Büttner-Herold M, et al. Conference contribution CD137 (4-1BB) triggering leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity (2021) Stoll A, Bruns H, Gamali S, Saul D, Fuchs M, Nimmerjahn F, Kunz M, et al. Conference contribution How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution NK cell metabolism is altered in early relapsing/refractory lymphoma patients upon autologous stem cell transplantation (2021) Jacobs B, Richter S, Böttcher M, Mackensen A, Mougiakakos D, Völkl S Conference contribution